Bellevue Group’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-99,000
| Closed | -$417K | – | 139 |
|
|
2017
Q1 | $417K | Sell |
99,000
-141,000
| -59% | -$594K | 0.06% | 126 |
|
|
2016
Q4 | $991K | Hold |
240,000
| – | – | 0.2% | 86 |
|
|
2016
Q3 | $1.94M | Sell |
240,000
-180,000
| -43% | -$1.46M | 0.35% | 77 |
|
|
2016
Q2 | $3.28M | Hold |
420,000
| – | – | 0.62% | 52 |
|
|
2016
Q1 | $3.24M | Buy |
+420,000
| New | +$3.24M | 0.59% | 54 |
|